Since 2022, NCSL has tracked 66 bills in 25 states addressing GLP-1s for obesity treatment, with at least six states expanding access and others restricting it
These gastrointestinal issues can be exacerbated by travel-related stressors, changes in diet, or dehydration, potentially leading to more serious conditions like kidney problems
We will assist you as you discover fitting treatments
Retatrutide Peptide Nasal Spray: Mechanism of Action As mentioned earlier, Retatrutide functions by mimicking hormones such as GLP-1, GIP, and glucagon
Patients with diabetes are generally at higher risk of certain infections due to elevated blood glucose levels impairing immune cell function, but improved glycaemic control achieved with GLP-1 therapy may actually reduce this baseline infection risk
Abstract Glucagon-like peptide-1 receptor analogs (GLP-1 RAs) have been an innovative and instrumental drug class in the management of both type 2 diabetes and obesity